Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
28.88
+0.43 (1.51%)
Nov 21, 2024, 4:00 PM EST - Market closed
Castle Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 809 | 581 | 620 | 1,103 | 1,622 | 587 | |
Market Cap Growth | 74.70% | -6.38% | -43.76% | -32.00% | 176.41% | - | |
Enterprise Value | 544 | 366 | 368 | 740 | 1,461 | 517 | |
Last Close Price | 28.45 | 21.58 | 23.54 | 42.87 | 67.15 | 34.37 | |
PE Ratio | 137.28 | - | - | - | - | 196.20 | |
PS Ratio | 2.51 | 2.64 | 4.53 | 11.72 | 25.89 | 11.31 | |
PB Ratio | 1.80 | 1.48 | 1.55 | 2.68 | 3.90 | 6.89 | |
P/TBV Ratio | 2.39 | 2.12 | 2.27 | 3.42 | 3.90 | 6.89 | |
P/FCF Ratio | 23.38 | - | - | - | 317.18 | 96.55 | |
P/OCF Ratio | 13.67 | - | - | - | 164.43 | 83.65 | |
EV/Sales Ratio | 1.74 | 1.66 | 2.68 | 7.86 | 23.33 | 9.97 | |
EV/EBITDA Ratio | 43.80 | - | - | - | - | 67.30 | |
EV/EBIT Ratio | - | - | - | - | - | 70.59 | |
EV/FCF Ratio | 15.74 | - | - | - | 285.78 | 85.10 | |
Debt / Equity Ratio | 0.06 | 0.04 | 0.03 | 0.02 | - | 0.30 | |
Debt / EBITDA Ratio | 1.74 | - | - | - | - | 3.27 | |
Debt / FCF Ratio | 0.77 | - | - | - | - | 4.13 | |
Asset Turnover | 0.66 | 0.49 | 0.30 | 0.21 | 0.22 | 0.73 | |
Inventory Turnover | 9.15 | 7.55 | 10.67 | 7.47 | 5.61 | 6.90 | |
Quick Ratio | 7.45 | 5.90 | 7.81 | 13.94 | 20.24 | 7.42 | |
Current Ratio | 7.78 | 6.20 | 8.09 | 14.21 | 20.58 | 7.63 | |
Return on Equity (ROE) | 1.47% | -14.54% | -16.56% | -7.56% | -4.11% | 14.06% | |
Return on Assets (ROA) | -0.14% | -9.43% | -12.52% | -5.55% | -1.88% | 6.44% | |
Return on Capital (ROIC) | -0.15% | -10.37% | -13.68% | -5.99% | -2.00% | 7.35% | |
Earnings Yield | 0.75% | -9.90% | -10.82% | -2.84% | -0.63% | 0.90% | |
FCF Yield | 4.28% | -3.31% | -7.62% | -2.04% | 0.32% | 1.04% | |
Buyback Yield / Dilution | -6.54% | -2.87% | -3.65% | -32.80% | -118.63% | -354.25% | |
Total Shareholder Return | -6.54% | -2.87% | -3.65% | -32.80% | -118.63% | -354.25% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.